세부 프로그램
시간 | Session A | 연자/좌장 |
---|---|---|
12:40-13:55 | Multidimensional Immune Cell Analysis | 박윤 (KIST) 김태균 (연세대) |
12:40-13:10 | From Terminology to Insight | Shirly Phoon (Beckman Coulter Lifescience) |
13:10-13:35 | Spatial multi-omics in immunology research | 김종훈 (연세대) |
13:35-13:55 | Multimodal and multiscale imaging of CAR T cells in a pancreatic adenocarcinoma xenograft model reveals negative effects of local IL-2 administration | Rita Pfeifer (Miltenyi Biotec B.V. & Co. KG) |
13:55-14:10 | Break | |
14:10-15:25 | Immune Cell Analysis with bulk RNA Seq | 최윤수 (서울대) |
14:10-15:25 | Introduction to bulk RNA-seq data analysis | 김광수 (서울대) |
15:25-15:40 | Break | |
15:40-16:55 | [Industrial Session] Development of Novel Immunotherapeutics: Antibodies and Microbiome *[건국의대 톨유사수용체 기반 질병 연구 센터] |
박영민 (건국대) 박수형 (KAIST) |
15:40-16:05 | Mechanisms of Anticancer Activity of Bacteria in Enhancing Cancer Immunotherapy | 박창욱 (이뮤노바이옴㈜) |
16:05-16:30 | ㈜ MD Healthcare | 김윤근 (㈜ MD 헬스케어) |
16:30-16:55 | ㈜ ABL바이오- ABL503, a PD-L1 and 4-1BB Dual-Targeting Bispecific Antibody | 정재호 (㈜ ABL바이오) |
16:55-17:10 | Break | |
17:10-18:00 | Special Symposium: Virus & Host Defense | 송만기 (국제백신연구소) |
17:10-17:40 | T cell immune responses against SARS-CoV-2 | 신의철 (IBS) |
17:40-18:10 | age- and clade-dependent differential parthenogenesis of SARS-CoV-2 in animal models | 최영기 (IBS) |
시간 | Session B | 연자/좌장 |
---|---|---|
Overview | 이상일 (대한면역학회 총무위원장) | |
12:40-13:55 | 면역학연구 진흥을 위한 초청 강연 | 임종석 (숙명여대) |
12:40-13:10 | 바이오분야 R&D 현황 및 추진계획(신약개발분야 R&D 현황) | 김상현 단장 (연구재단) |
13:10-13:40 | How to collaborate with Korean R&D community | 묵현상 단장 (국가신약개발사업단) |
13:40-13:55 | Discussion (Q&A) | |
13:55-14:10 | Break | |
14:10-15:25 | Animal Models of Immune Disorders | 최제민 (한양대) 곽승기 (가톨릭대) |
14:10-14:35 | Mind the gap between animal model and human patients in COVID19 infection | 성제경 (서울대) |
14:35-15:00 | Animal models of systemic autoimmune disease I | 조미라 (가톨릭대) |
15:00-15:25 | Animal models of systemic autoimmune disease II | 곽승기 (가톨릭대) |
15:25-15:40 | Break | |
15:40-16:55 | [Industrial Session] Development of Novel Immunotherapeutics: Antibodies and Microbiome *[건국의대 톨유사수용체 기반 질병 연구 센터] |
박영민 (건국대) 박수형 (KAIST) |
15:40-16:05 | Mechanisms of Anticancer Activity of Bacteria in Enhancing Cancer Immunotherapy | 박창욱 (이뮤노바이옴㈜) |
16:05-16:30 | ㈜ MD Healthcare | 김윤근 (㈜ MD 헬스케어) |
16:30-16:55 | ㈜ ABL바이오- ABL503, a PD-L1 and 4-1BB Dual-Targeting Bispecific Antibody | 정재호 (㈜ ABL바이오) |
16:55-17:10 | Break | |
17:10-18:00 | Special Symposium: Virus & Host Defense | 송만기 (국제백신연구소) |
17:10-17:40 | T cell immune responses against SARS-CoV-2 | 신의철 (IBS) |
17:40-18:10 | age- and clade-dependent differential parthenogenesis of SARS-CoV-2 in animal models | 최영기 (IBS) |